A new antiviral blocks 6 deadly viruses in mice but faces a long road ahead

A sugar on the viruses may be their weak spot. Questions about potency and resistance remain

A colorized electron microscope image of the Ebola virus, shown as a long, red filamentous structure against a background of blue cell-like shapes.

Particles of Ebola virus (one shown in a scanning electron micrograph) use a specific sugar to enter host cells. That sugar is now the target for broad spectrum antiviral medications.

National Institute of Allergy and Infectious Diseases, National Institutes of Health

A sugar present on virus envelopes might become the target of new antiviral treatments for a range of viruses, researchers report August 27 in Science Advances.